PPD (PPD) Buildings And Improvements : $0 Mil (As of Sep. 2021)

View and export this data going back to 2020. Start your Free Trial

What is PPD Buildings And Improvements?

PPD's annual buildings and improvements increased from Dec. 2018 ($345 Mil) to Dec. 2019 ($385 Mil) and increased from Dec. 2019 ($385 Mil) to Dec. 2020 ($444 Mil).

PPD Buildings And Improvements Historical Data

The historical data trend for PPD's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PPD Buildings And Improvements Chart

PPD Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Buildings And Improvements

326.28

345.26

384.98

443.57

PPD Quarterly Data
	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
Buildings And Improvements	Get a 7-Day Free Trial									-	443.57	-	-	-

PPD Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

PPD (PPD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PPD Inc (NAS:PPD) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

929 North Front Street, Wilmington, NC, USA, 28401

Website

https://www.ppdi.com

PPD is a global contract research organization that provides clinical trial and laboratory services to pharmaceutical, device, and diagnostic firms. The clinical development services segment offers outsourced trial services, spanning early- and late-stage trials, as well as peri- and post-approval trials, and the laboratory services segment includes both advanced lab testing and central lab services. The company was taken private in 2011 and went public again in 2020.. Thermo Fisher Scientific announced it will acquire PPD for $17.4 billion, which is scheduled to close by the end of 2021.

Executives

H&f Corporate Investors Viii, Ltd.	10 percent owner	415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
H&f Corporate Investors Vii, Ltd.	10 percent owner	415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
David Michael Johnston	officer: See Remarks	C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
David S Simmons	director, officer: Chief Executive Officer	PFIZER INC. ATTN. CORP. SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017
Glen Donovan	officer: Chief Accounting Officer	C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
Ronald E Garrow	officer: See Remarks	2000 PURCHASE STREET, PURCHASE NY 10577
Karen Kaucic	officer: See Remarks	C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
Judd Hartman	officer: See Remarks	3124 DEVER COURT WILMINGTON NC 28411
Jill Pellegrino	officer: SVP & General Manager of AES	C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
H&f Executives Vii, L.p.	10 percent owner	ONE MARITIME PLAZA 12TH FLOOR SAN FRANCISCO CA 94111
Hellman & Friedman Investors Viii, L.p.	10 percent owner	415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
P. Hunter Philbrick	director	C/O HELLMAN & FRIEDMAN INVESTORS, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111
Carlyle Partners Vi Holdings Ii, L.p.	10 percent owner	C/O THE CARLYLE GROUP, SUITE 220 SOUTH 1001 PENNSYLVANIA AVENUE, N.W. WASHINGTON DC 20004
Tc Group Vi, L.l.c.	10 percent owner	C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA ANVENE, N.W., WASHINGTON DC 20004
Tc Group Vi, L.p.	10 percent owner	C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004